BDBM511700 (3S)-5-(6-azaspiro[2.5]octan-6- ylmethyl)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 5::US11708351, Compound 5

SMILES CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCC4(CC4)CC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1

InChI Key InChIKey=FEILZJNJTHZROU-LCOPZMBYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511700   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511700((3S)-5-(6-azaspiro[2.5]octan-6- ylmethyl)-2-(2-(3-...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511700((3S)-5-(6-azaspiro[2.5]octan-6- ylmethyl)-2-(2-(3-...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent